RNAZ TRANSCODE THERAPEUTICS INC
FollowCOM NEW 2025 (common), issuer CIK 1829635
7 managers (8 13F filers) reported a position in RNAZ shares at 2026-03-31, 30,865 shares in all. 2 filers opened a position and 2 filers sold out during the quarter.
- Managers
- 7
- 13F filers
- 8
- New
- 2
- Added
- 2
- Reduced
- 1
- Sold out
- 2
- Shares held by filers
- 30,865
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2026
Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 12,740 | $110K | <0.01% | new | 13F-HRTimelineGroup |
| VANGUARD GROUP INCgroup of 2 filers holding | 9,527 | $82K | new | Timeline
| |
| UBS Group AGin group UBS Group AG | 8,295 | $71.4K | <0.01% | +5,331 | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 228 | $1.96K | <0.01% | -659 | 13F-HRTimelineGroup |
| WELLS FARGO & COMPANY/MNin group WELLS FARGO & COMPANY/MN | 55 | $474 | <0.01% | new | 13F-HR/ATimelineGroup |
| SBI Securities Co., Ltd. | 12 | $103 | <0.01% | +2 | 13F-HRTimeline |
| ROYAL BANK OF CANADAin group ROYAL BANK OF CANADA | 8 | $0 | 0% | 0 | 13F-HRTimelineGroupValue filed as zero, left out of ratios. |